Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure

American Journal of Medicine

Volumn 113, Issue 9, 2002, Pages 717-722

  Setsuta, Koichi ^a   Seino, Yoshihiko ^b,d   Ogawa, Takeshi ^c   Arao, Masato ^a   Miyatake, Yoshiko ^a   Takano, Teruo ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c Hakujikai Memorial Hospital   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN; NORADRENALIN; TROPONIN T;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CYTOSOL; DEATH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE FIBRIL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEX; SEX DIFFERENCE; SYMPTOM;

AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NEOPLASM PROTEINS; TIME FACTORS; TROPONIN T; TUMOR SUPPRESSOR PROTEINS;

EID: 0037115529     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01394-3     Document Type: Article

References (23)

1. Setsuta K., Seino Y., Takahashi N., et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol. 148:1999;141-149.
2. Sato Y., Yamada T., Taniguchi R., et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation. 103:2001;369-374.
3. Glatz J.F.C., Paulussen R.J.A., Veerkamp J.H. Fatty acid-binding proteins from heart. Chem Phys Lipids. 38:1985;115-129.
4. Schaap F.G., Van der Vusse G.J., Glatz J.F.C. Fatty acid-binding proteins in the heart. Mol Cell Biochem. 180:1998;43-51.
5. Glatz J.F.C., Van Bilsen M., Paulussen R.J.A., et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta. 961:1988;148-152.
6. Tanaka T., Hirota Y., Sohmiya K., et al. Serum and urinary human fatty acid-binding protein in acute myocardial infarction. Clin Biochem. 24:1991;195-201.
7. Kleine A.H., Glatz J.F.C., Van Nieuwenhoven F.A., et al. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem. 116:1992;155-162.
8. Ohkaru Y., Asayama K., Ishii H., et al. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart type fatty acid-binding protein. J Immunol Methods. 178:1995;99-111.
9. Wodzig K.W., Kragten J.A., Hermens W.T., et al. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function. Eur J Clin Chem Clin Biochem. 35:1997;191-198.
10. Gorski J., Hermens W.T., Borawski J., et al. Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clin Chem. 43:1997;193-195.
11. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction . Circulation. 96:1997;509-516.
12. Francis G.S., Cohn J.N., Johnson G., et al. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relation to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation. 87:(suppl 6):1993;140-148.
13. Davies C.H., Harding S.E., Poole-Wilson P.A. Cellular mechanisms of contractile dysfunction in human heart failure. Eur Heart J. 335:1996;1182-1189.
14. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
15. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
16. Mair J. Cardiac troponin I and T are enzymes still relevant as cardiac markers? Clin Chim Acta. 257:1997;99-115.
17. Katus H.A., Remppis A., Scheffold T., et al. Intracellular compartmentation of cardiac troponin T and its release kinetics inpatients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 67:1991;1360-1367.
18. Adams J.E., Schechtman K.B., Landt Y., et al. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem. 40:1994;1291-1295.
19. Yoshimoto K., Tanaka T., Somiya K., et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels. 10:1995;304-309.
20. Mancini D.M., Coyle E., Coggan A., et al. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle abnormalities in patients with chronic heart failure. Circulation. 80:1989;1338-1346.
21. Sullivan M.J., Green H.J., Cobb F.R. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 81:1990;518-527.
22. Escudo G., Zennaro R., Sandri M., et al. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol. 30:1998;2449-2459.
23. Van Nieuwenhoven F.A., Kleine A.H., Wodzig W.H., et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation. 10:1995;2848-2854.